Infectious Complications in Hematopoietic Stem Cell Transplantation
Submission Deadline: June 30, 2019 (Open) Submit Now
Dora Ho, MD, PhD
Clinical Associate Professor, Clinical Chief, Division and Infectious Diseases & Geographic Medicine, Department of Medicine, Stanford University, USA
E-Mail: [email protected]
Research Interests: Infectious Diseases, Immunocompromised Host, infection complications in immunocompromised patients, such as those with bone marrow transplant, solid organ transplant, cancers and other forms of immunodeficiency
About the Topic
Hematopoietic cell transplantation (HCT) is a life-saving procedure for many patients, but depending of the specific types of transplant and the protocols employed, transplant recipients may face various peri- or post-transplant complications that can cause significant morbidity and mortality. In particular, HCT recipients are at substantial risk for infections, from those of nosocomial nature that affect hospitalized patients in general, to those rare opportunistic infections that manifest only in profoundly immunocompromised hosts. Caring for HCT patients demands much expertise and dedication. Especially, Infectious Diseases physicians that specialize in HCT need to familiarize themselves with the basic principles of HCT and understand the functioning of the immune system at different time of the HCT process. They also need to be aware of the HCT recipients’ risk factors to various types of infection and be knowledgeable of a myriad of clinical syndromes associated with HCT, from both infectious and noninfectious etiologies.
In this particular issue of the journal, authors are invited to share their experiences and challenges regarding infectious complications in HCT, in the form of editorials, case reports, clinical research articles and reviews and so on.